A look at Perspective Therapeutics Inc’s (CATX) recent performance gives investors their first glimpse of hope.

On Friday, Perspective Therapeutics Inc (AMEX: CATX) opened lower -11.66% from the last session, before settling in for the closing price of $8.92. Price fluctuations for CATX have ranged from $2.28 to $19.05 over the past 52 weeks.

Company’s average yearly earnings per share was noted 49.13% at the time writing. With a float of $48.44 million, this company’s outstanding shares have now reached $67.59 million.

The firm has a total of 119 workers. Let’s measure their productivity. In terms of profitability, gross margin is 3.58%, operating margin of -642.65%, and the pretax margin is -621.47%.

Perspective Therapeutics Inc (CATX) Insider Activity

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Perspective Therapeutics Inc is 28.33%, while institutional ownership is 76.12%. The most recent insider transaction that took place on Sep 12 ’24, was worth 39,500. Before that another transaction happened on Jun 17 ’24, when Company’s Chief Financial Officer bought 1,800 for $9.81, making the entire transaction worth $17,667. This insider now owns 35,971 shares in total.

Perspective Therapeutics Inc (CATX) Earnings and Forecasts

If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.9 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.4) by -0.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 49.13% per share during the next fiscal year.

Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators

Check out the current performance indicators for Perspective Therapeutics Inc (CATX). In the past quarter, the stock posted a quick ratio of 9.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 53.22.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.19 in one year’s time.

Technical Analysis of Perspective Therapeutics Inc (CATX)

Analysing the last 5-days average volume posted by the [Perspective Therapeutics Inc, CATX], we can find that recorded value of 1.22 million was better than the volume posted last year of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 1.44%. Additionally, its Average True Range was 0.80.

During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 0.12%, which indicates a significant decrease from 0.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.31% in the past 14 days, which was lower than the 73.03% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $12.55, while its 200-day Moving Average is $12.82. Now, the first resistance to watch is $8.58. This is followed by the second major resistance level at $9.29. The third major resistance level sits at $9.64. If the price goes on to break the first support level at $7.52, it is likely to go to the next support level at $7.17. Should the price break the second support level, the third support level stands at $6.46.

Perspective Therapeutics Inc (AMEX: CATX) Key Stats

There are currently 67,588K shares outstanding in the company with a market cap of 470.49 million. Presently, the company’s annual sales total 1,430 K according to its annual income of -46,510 K. Last quarter, the company’s sales amounted to 530 K and its income totaled -11,700 K.